Goldman Sachs upgraded Mead Johnson Nutrition (NYSE: MJN) from Neutral to Conviction Buy with a price target of $95.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE